{"id": "1359702447791378434", "creation": 1613013300.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 1}}, "text": "Chinese company Shenzhen Kangtai Biological Products Co. Ltd. (SZKT) signed an agreement on Feb. 9 with Malaysian public listed company Yong Tai Bhd (YTB) for the procurement, phase 3 clinical trials and exclusive commercialization of its inactivated #COVID19 #vaccine candidate. https://t.co/Kd67rCXJTM", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}